United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - ephedrine sulfate (unii: u6x61u5zeg) (ephedrine - unii:gn83c131xs) - ephedrine sulfate injection is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. none risk summary available data from randomized studies, case series, and reports of ephedrine sulfate use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. however, there are clinical considerations due to underlying conditions (see clinical considerations) . in animal reproduction studies, decreased fetal survival and fetal body weights were observed in the presence of maternal toxicity after normotensive pregnant rats were administered 60 mg/kg intravenous ephedrine sulfate (12 times the maximum recommended human dose (mrhd) of 50 mg/day).  no malformations or embryofetal adverse effects were observed when pregnant rats or rabbits were treated with intravenous bolus doses of ephedrine sulfate during organogenesis at doses 1.9 and 7.7 times the mrhd, respectively [see data] . the

Kenya - English - Pharmacy and Poisons Board

ephedrine hydrochloride - nasal drops - each ml contains: ephedrine hcl 10 mg (1.0 % w/v) - ephedrine

Ireland - English - HPRA (Health Products Regulatory Authority)

johnson & johnson (ireland) limited - pseudoephedrine hydrochloride ; dextromethorphan hydrobromide ; triprolidine hydrochloride - syrup - 30/10/1.25 milligram - pseudoephedrine, combinations

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - ephedrine hydrochloride - solution for injection - 30mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - ephedrine hydrochloride - solution for injection - 3mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - ephedrine hydrochloride - solution for injection - 3mg/1ml

United States - English - NLM (National Library of Medicine)

nexus pharamaceuticals inc. - ephedrine sulfate (unii: u6x61u5zeg) (ephedrine - unii:gn83c131xs) - emerphed is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. none risk summary available data from randomized studies, case series, and reports of ephedrine sulfate use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. however, there are clinical considerations [see clinical considerations ]. in animal reproduction studies, decreased fetal survival and fetal body weights were observed in the presence of maternal toxicity after normotensive pregnant rats were administered 60 mg/kg intravenous ephedrine sulfate (12 times the maximum recommended human dose (mrhd) of 50 mg/day). no malformations or embryofetal adverse effects were observed when pregnant rats or rabbits were treated with intravenous bolus doses of ephedrine sulfate during organogenesis at doses 1.9 and 7.7 times the mrhd, respectively [see data ]. the estimated background risk of major birth defects and misc

United States - English - NLM (National Library of Medicine)

paddock laboratories, llc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - hydrocodone bitartrate 5 mg in 5 ml - hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is indicated for the temporary relief of cough and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold in patients 18 years of age and older. important limitations of use hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is contraindicated for: hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is also contraindicated in patients with: risk summary hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is not recommended for use in pregnant women, including during or immediately prior to labor. prolonged use of opioids during pregnancy may cause neonatal opioid withdrawal syndrome [see warnings and precautions (5.13), clinical considerations ]. there are no available data with hydrocodone bitartrate, chlorpheniramine maleate and pseudo

United States - English - NLM (National Library of Medicine)

dickey consumer products dba dmd - ephedrine hydrochloride (unii: nlj6390p1z) (ephedrine - unii:gn83c131xs), guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - purposes - bronchodilator, expectorant • for temporary relief of mild symptoms of intermittent asthma: • wheezing • tightness of chest • shortness of breath. helps loosen phlegm (mucus) and thin bronchial secretions to rid bronchial passageways of bothersome mucus, and to make coughs more productive.

United States - English - NLM (National Library of Medicine)

walgreen company - ephedrine hydrochloride (unii: nlj6390p1z) (ephedrine - unii:gn83c131xs) - purpose bronchodilator  for temporary relief of mild symptoms of intermittent asthma:  wheezing  tightness of chest  shortness of breath